Altimmune, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Altimmune, Inc. Website Screenshot

http://altimmune.com

Altimmune, Inc. Company Intro

Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies. Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B, and conjugated immunostimulants for the treatment of cancer. In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19.

Industry

Healthcare

Altimmune, Inc. Headquaters

910 Clopper Road
Gaithersburg,20878
United States


Altimmune, Inc. Share price

22 Oct 2020 01:04 GMT

$11.28

-0.11 (-0.97 %)


Altimmune, Inc. Market cap

$363.675 M


WMC RANKING

2020

Altimmune, Inc. # 189

Biotechnology



Latest Altimmune, Inc. News

News 21 Oct 2020

Pay Attention to this Trade Activity as Altimmune Inc. (ALT) last week performance was -19.90%

Altimmune Inc. (NASDAQ: ALT) flaunted slowness of -6.56% at $11.39, as the Stock market unbolted on October 20, 2020. During the day, the stock rose to ...

News 21 Oct 2020

EPS Surprise As An Investment Strategy: Altimmune Inc. (ALT), Spectrum Pharmaceuticals Inc. (SPPI)

The total Institutional investors and hedge funds own 45.90% of the company's stock. In the most recent purchasing and selling session, Altimmune Inc. (ALT)'s ...

News 22 Oct 2020

Biodefense Market Prices Analysis 2020-2025 – TechnoWeekly

Altimmune Inc. ANP Technologies Inc. Bavarian Nordic AS Cleveland BioLabs Inc. Elusys Therapeutics Inc. Emergent BioSolutions Inc. General Dynamics Corp.

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Altimmune, Inc. 0.08 0 0 0 0 0 0
Alexion Pharmaceuticals, Inc. 100 13.15 100 19 0 0 98.93
Vertex Pharmaceuticals Incorporated 97.58 100 3.89 30 0 0 100
3SBio Inc. 96.05 0 0 4 0 0 3.02
Incyte Corporation 40.27 14.26 7.06 100 0 0 90.93

Altimmune, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Altimmune, Inc. $4,154 $44,464 $-35,689 $374.865M 189
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $27.177B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $55.881B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥20.867B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.532B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Altimmune, Inc. Social Followers vs Top 4 Industry Competitors



Altimmune, Inc. Post vs Top 4 Industry Competitors